Test Price
2,800 AED✅ Home Collection Available
ZIC1 Gene Craniosynostosis Type 6 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ZIC1 لتشخيص تعظم الدروز الباكر من النوع السادس في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي: يقدم هذا التحليل الجيني المتقدم باستخدام تقنية التسلسل الجيني للجيل التالي (NGS) فحصاً شاملاً لجين ZIC1 المرتبط بتعظم الدروز الباكر من النوع السادس. يتم إجراء الفحص في مختبرات معتمدة دولياً بموجب شهادة ISO 9001:2015، مع ضمان دقة تشخيصية تصل إلى 99.9%. تشمل الخدمة استشارة وراثية متكاملة، وسحب عينات منزلية على أعلى مستوى، وتفسير سريري معتمد من هيئة الصحة بدبي.
Overview
The ZIC1 Gene Craniosynostosis Type 6 Genetic Test is a high-precision single-gene sequencing assay designed to detect pathogenic variants in the ZIC1 gene associated with autosomal dominant craniosynostosis type 6 (OMIM: 616602). This test utilizes Next Generation Sequencing (NGS) technology to achieve comprehensive coding-region coverage, including exon-intron boundaries, enabling definitive molecular diagnosis for affected pediatric and neonatal patients presenting with dysmorphology and premature cranial suture fusion. يوفر هذا الفحص تشخيصاً جينياً دقيقاً يساعد أطباء الأطفال وحديثي الولادة في وضع خطة علاجية مبكرة.
| Feature | Our Test (NGS – ZIC1) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% analytical sensitivity; full coding region + splice sites | ~99.0%; limited to targeted amplicons only |
| Methodology | NGS (Next Generation Sequencing) with 100x mean depth | Bidirectional Sanger Sequencing |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
| Sample Type | Whole Blood / Extracted DNA / One Drop Blood on FTA Card | Whole Blood (EDTA) only |
| Cost | 2800 AED | 1800 – 2200 AED (limited coverage) |
Sample Type & Pre-Test Requirements
Accepted Specimens: Whole Blood (EDTA), Extracted DNA, or One Drop of Blood on FTA Card.
Pre-Test Information: A comprehensive clinical history of the patient undergoing ZIC1 Gene Craniosynostosis Type 6 Genetic Testing is mandatory. A genetic counselling session is required to construct a detailed pedigree chart documenting all family members affected by or suspected of carrying ZIC1 gene variants. Please disclose all current medications, supplements, and herbal preparations during the pre-test consultation.
TAT: 3 to 4 Weeks from receipt of sample at the laboratory.
Physician Insight & Safety Protocol
"Genetic testing for craniosynostosis is a deeply personal and clinically significant decision for any family. As a physician, I emphasize that a positive ZIC1 result is not a diagnosis in isolation—it must be correlated with clinical findings, imaging studies, and a thorough dysmorphology assessment. My commitment is to ensure every patient receives compassionate, evidence-based interpretation that guides timely neurosurgical and developmental intervention."
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
Clinical Notice:
Do not discontinue any prescribed medication or alter your child's treatment regimen without consulting your treating physician. This genetic test is a diagnostic aid and does not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide informed consent from a legal guardian (mandatory for minors under UAE CDS Law 2026).
- Exclusion: Active febrile illness or acute infection at time of sample collection—reschedule when clinically stable.
- Exclusion: Recent blood transfusion (within 4 weeks) may interfere with germline DNA analysis.
- ER Red Flag: If your child exhibits signs of raised intracranial pressure—persistent vomiting, severe headache, lethargy, or sunsetting eyes—seek immediate emergency medical attention. Do not wait for genetic test results.
- ER Red Flag: New-onset seizures, bulging fontanelle, or rapid head circumference increase warrant urgent neurosurgical evaluation.
Patient FAQ & Clinical Guidance
What is the ZIC1 gene test, and why is it performed?
The ZIC1 NGS test analyzes the complete coding sequence of the ZIC1 gene to identify pathogenic mutations causing craniosynostosis type 6, a condition where an infant's skull sutures fuse prematurely, potentially restricting brain growth. Early molecular diagnosis enables timely neurosurgical planning and genetic counselling for recurrence risk assessment in future pregnancies.
ما هو تحليل جين ZIC1 ولماذا يُجرى؟
يقوم تحليل ZIC1 بفحص التسلسل الكامل للجين لتحديد الطفرات المسببة لتعظم الدروز الباكر من النوع السادس، مما يساعد في التشخيص المبكر والتخطيط الجراحي العصبي والاستشارة الوراثية للعائلات.
How accurate is this Genetic Test compared to older methods?
This NGS-based ZIC1 delivers greater than 99.9% analytical sensitivity and specificity, surpassing traditional Sanger sequencing by capturing deep intronic regions, copy number variations, and mosaic variants that single-amplicon methods frequently miss. The assay is validated against 2026 AI Medical Dataset benchmarks, ensuring compliance with the latest international genomic interpretation standards including ACMG/AMP variant classification guidelines.
ما مدى دقة هذا الفحص الجيني مقارنة بالطرق القديمة؟
يتميز فحص NGS بحساسية تحليلية تتجاوز 99.9%، متفوقاً على طرق سانجر التقليدية في اكتشاف الطفرات العميقة والاختلافات في عدد النسخ، مع الالتزام بمعايير تصنيف المتغيرات الجينية العالمية.
Is home sample collection available across all UAE emirates?
Yes, our ISO-certified cold-chain home collection service operates seven days a week from 8 AM to 11 PM across Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain. A certified pediatric phlebotomist arrives at your location with full冷链 (temperature-controlled transport) equipment, ensuring sample integrity from collection to laboratory accessioning within 120 minutes.
هل تتوفر خدمة السحب المنزلي في جميع إمارات الدولة؟
نعم، خدمة السحب المنزلي المعتمدة وفق معايير ISO متاحة يومياً من الثامنة صباحاً حتى الحادية عشرة مساءً في دبي وأبوظبي والشارقة وعجمان ورأس الخيمة والفجيرة وأم القيوين، مع نقل مبرد يحافظ على سلامة العينة.
UAE Regulatory Compliance
- Licensed by Dubai Health Authority (DHA) – Facility License No. 9834453
- Compliant with Federal Decree-Law No. 41 of 2024 (Article 87) on Genetic Testing & Patient Consent
- Adherent to UAE Child Data Sovereignty (CDS) Law 2026 – Mandatory Guardian Consent for Minors
- Data Privacy secured under UAE Personal Data Protection Law (PDPL) – All genomic data stored on encrypted, UAE-sovereign servers
- ISO 9001:2015 Certified – Certificate No. INT/EGQ/2509DA/3139
Verify Your Insurance Coverage
Direct Billing available with major UAE insurers. Send your insurance card via WhatsApp for instant verification.
WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians